✦ LIBER ✦

Criteria for the choice and definition of healthy volunteers and or patients for phase I and phase II studies in drug development

✍ Scribed by P. R. Bechtel; G. Alvan

Publisher: Springer
Year: 1989
Tongue: English
Weight: 149 KB
Volume: 36
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00637733

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, cisplatin, and 13-Cis retino

Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck : A Phase I–II study

✍ Francesco Recchia; Angelo Lalli; Marco Lombardo; Sandro De Filippis; Gaetano Sag 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 3 views

Hyperthermia for the treatment of patien

Hyperthermia for the treatment of patients with malignant germ cell tumors : A Phase I/II study in ten children and adolescents with recurrent or refractory tumors

✍ Rüdiger Wessalowski; Heidi Kruck; Hildegard Pape; Thomas Kahn; Reinhart Willers; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 3 views

waves in combination with platinum-based chemotherapy in ten children and 4 Institute of Statistics, Heinrich-Heine Univeradolescents with recurrent or refractory GCTs. sity, Du ¨sseldorf, Germany. ## RESULTS. Seven of ten patients with recurrent or refractory GCTs had objective responses. Of the

The multifractionated, twice-weekly dose

The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen : A Phase I–II study of paclitaxel, cisplatin, and vinorelbine

✍ Jacob J. Lokich; Norwood Anderson; Murray Bern; Frank Coco; Edward Dow 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

## Background: Paclitaxel, cisplatin, and vinorelbine are three important antineoplastic drugs with different mechanisms of cell kill. a combination of these three drugs potentially could have additive therapeutic effects. methods. the three-drug combination (designated tpn) was administered on a t

Development of the Berlin Symptom Checkl

Development of the Berlin Symptom Checklist Ovary (BSCL-O) for the measurement of quality of life of patients with primary and recurrent ovarian cancer: results of a phase I and II study

✍ Dominique Koensgen; Guelten Oskay-Oezcelik; Ioanna Katsares; Ulla Walle; Christi 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Palonosetron for the prevention of chemo

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study

✍ Antonio Rozzi; Chiara Nardoni; Michela Corona; Maria Rosa Restuccia; Alessandra 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 114 KB

Oral topotecan in children with recurren

Oral topotecan in children with recurrent or progressive high-grade glioma : A Phase I/II study by the German Society for Pediatric Oncology and Hematology

✍ Sabine Wagner; Bernhard Erdlenbruch; Alfred Längler; Astrid Gnekow; Joachim Kühl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

## Abstract ## BACKGROUND Continuous oral treatment with topotecan may be more effective than the typical 1‐day and 5‐day treatment schedules. In previous studies of continuous treatment with topotecan, increased intestinal side effects were reported in adult patients; however, the experience in p